Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis

Konstantinos H. Katsanos, Evangelos Briasoulis, P. Tsekeris, Anna Batistatou, Maria Bai, Christos Tolis, Antonio Capizzello, Ioannis Panelos, Vasilios Karavasilis, Dimitrios Christodoulou,

Journal of Experimental & Clinical Cancer Research · 2010 · 20 citations · 30 references

DOIFull text

Open access

Abstract

Amifostine given subcutaneously can lower the risk of acute severe radiation colitis in patients who receive radical radiotherapy to pelvic tumors.

References

30